Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-na?ve patients with early rheumatoid arthritis: HIT HARD, aninvestigator-initiated study
作者:
发布时间
2018-06-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文